U.S. Physical Therapy, Inc.
USPH
$74.75
$0.330.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.10% | 16.39% | 14.31% | 12.12% | 8.90% |
| Total Other Revenue | 17.84% | 23.27% | 26.67% | 26.38% | 22.77% |
| Total Revenue | 16.39% | 17.51% | 16.25% | 14.31% | 10.99% |
| Cost of Revenue | 16.23% | 20.68% | 18.12% | 15.83% | 12.13% |
| Gross Profit | 16.95% | 7.48% | 10.12% | 9.13% | 7.12% |
| SG&A Expenses | 18.82% | 17.81% | 17.31% | 15.85% | 12.20% |
| Depreciation & Amortization | 17.85% | -18.31% | -9.41% | 3.60% | 19.45% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.54% | 18.52% | 16.89% | 15.41% | 12.35% |
| Operating Income | 15.16% | 9.19% | 11.04% | 5.45% | 0.69% |
| Income Before Tax | 29.24% | 93.31% | 55.47% | 26.23% | 21.94% |
| Income Tax Expenses | 35.59% | 95.03% | 53.69% | 24.37% | 20.18% |
| Earnings from Continuing Operations | 27.20% | 92.76% | 56.05% | 26.84% | 22.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.95% | -85.47% | -73.89% | -66.07% | -57.84% |
| Net Income | 25.96% | 95.63% | 49.89% | 15.25% | 11.28% |
| EBIT | 15.16% | 9.19% | 11.04% | 5.45% | 0.69% |
| EBITDA | 16.15% | 14.69% | 15.17% | 9.76% | 4.06% |
| EPS Basic | -22.76% | 154.24% | 116.55% | 76.87% | 37.38% |
| Normalized Basic EPS | -5.47% | -27.95% | -20.35% | -22.07% | -20.72% |
| EPS Diluted | -22.76% | 154.24% | 116.55% | 76.87% | 37.38% |
| Normalized Diluted EPS | -5.47% | -27.95% | -20.35% | -22.07% | -20.72% |
| Average Basic Shares Outstanding | 0.74% | 0.78% | 0.72% | 2.83% | 6.23% |
| Average Diluted Shares Outstanding | 0.74% | 0.78% | 0.72% | 2.83% | 6.23% |
| Dividend Per Share | 2.27% | 2.29% | 2.30% | 2.31% | 2.33% |
| Payout Ratio | -0.18% | -0.47% | -0.31% | -0.05% | -0.01% |